These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30194587)

  • 41. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
    Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.
    Staprans S; Marlowe N; Glidden D; Novakovic-Agopian T; Grant RM; Heyes M; Aweeka F; Deeks S; Price RW
    AIDS; 1999 Jun; 13(9):1051-61. PubMed ID: 10397535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.
    Harrington PR; Schnell G; Letendre SL; Ritola K; Robertson K; Hall C; Burch CL; Jabara CB; Moore DT; Ellis RJ; Price RW; Swanstrom R
    AIDS; 2009 May; 23(8):907-15. PubMed ID: 19414991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological markers in the cerebrospinal fluid of HIV-1-infected children.
    Gallo P; Laverda AM; De Rossi A; Pagni S; Del Mistro A; Cogo P; Piccinno MG; Plebani A; Tavolato B; Chieco-Bianchi L
    Acta Paediatr Scand; 1991; 80(6-7):659-66. PubMed ID: 1867084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV.
    Cusato J; Manca A; Palermiti A; Mula J; Avataneo V; Antonucci M; Marinaro L; Bonora S; Trunfio M; Di Perri G; D'Avolio A; Calcagno A
    Int J Antimicrob Agents; 2024 Jun; 63(6):107137. PubMed ID: 38508536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
    Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
    Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
    Bogoch II; Davis BT; Venna N
    J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
    Gisslén M; Heslegrave A; Veleva E; Yilmaz A; Andersson LM; Hagberg L; Spudich S; Fuchs D; Price RW; Zetterberg H
    Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e512. PubMed ID: 30568991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
    Peluso MJ; Ferretti F; Peterson J; Lee E; Fuchs D; Boschini A; Gisslén M; Angoff N; Price RW; Cinque P; Spudich S
    AIDS; 2012 Sep; 26(14):1765-74. PubMed ID: 22614889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
    Suh J; Sinclair E; Peterson J; Lee E; Kyriakides TC; Li FY; Hagberg L; Fuchs D; Price RW; Gisslen M; Spudich S
    J Neuroinflammation; 2014 Dec; 11():199. PubMed ID: 25465205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.
    McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A
    Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
    Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
    BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
    Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H
    BMC Neurol; 2009 Dec; 9():63. PubMed ID: 20028512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
    Edén A; Marcotte TD; Heaton RK; Nilsson S; Zetterberg H; Fuchs D; Franklin D; Price RW; Grant I; Letendre SL; Gisslén M
    PLoS One; 2016; 11(6):e0157160. PubMed ID: 27295036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
    Aweeka F; Jayewardene A; Staprans S; Bellibas SE; Kearney B; Lizak P; Novakovic-Agopian T; Price RW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):39-43. PubMed ID: 9928728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.
    Gisslén M; Fuchs D; Svennerholm B; Hagberg L
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):271-6. PubMed ID: 10428104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.